Patent · US Active

Compositions and methods for treatment of leukemia

US8993552B2 · kind B2 · utility

17Cited by
1References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 3, 2010
Grant dateMar 31, 2015
Priority date
Expiry dateSep 3, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates generally to effective treatment leukemia. In particular, the present invention provides compositions and methods to inhibit the interaction of menin with MLL and MLL-fusion oncoproteins, and well as systems and methods to screen for such compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.